Apyx Medical (NASDAQ:APYX) Price Target Cut to

09:56am, Saturday, 21'st Mar 2020
Apyx Medical (NASDAQ:APYX) had its target price lowered by Piper Sandler from to in a report published on Tuesday morning, The Fly reports. Piper Sandler also issued estimates for Apyx Medical’s Q1
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
Apyx Medical Corp (NASDAQ:APYX) – Stock analysts at Piper Sandler issued their Q1 2020 earnings estimates for shares of Apyx Medical in a research note issued on Monday, March 16th. Piper Sandler an
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ...
Apyx Medical Corp (NASDAQ:APYX) has been given an average recommendation of “Buy” by the seven brokerages that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the
State Street Corp increased its stake in Apyx Medical Corp (NASDAQ:APYX) by 10.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The in
Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery m
Archon Capital Management LLC lessened its stake in Apyx Medical Corp (NASDAQ:APYX) by 1.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Blockchain KYC-as-a-Service platform Blockpass and J. Rotbart & Co., today unveiled a partnership to offer precious metal services to PASS Club
Apyx Medical (NASDAQ:APYX) is set to release its earnings data after the market closes on Monday, March 16th. Analysts expect Apyx Medical to post earnings of ($0.16) per share for the quarter. Indivi
Equities research analysts expect Apyx Medical Corp (NASDAQ:APYX) to post ($0.16) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimat
Apyx Medical (NASDAQ:APYX) was upgraded by investment analysts at ValuEngine from a “buy” rating to a “strong-buy” rating in a note issued to investors on Tuesday, ValuEngine reports. A number
California Public Employees Retirement System increased its position in Apyx Medical Corp (NASDAQ:APYX) by 133.5% in the 4th quarter, according to its most recent disclosure with the Securities and Ex
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE